These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 3498816

  • 1. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW, Duffy P, Latimer LG.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [Abstract] [Full Text] [Related]

  • 2. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
    Kalivas PW, Duffy P.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
    [Abstract] [Full Text] [Related]

  • 3. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG, Duffy P, Kalivas PW.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [Abstract] [Full Text] [Related]

  • 4. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress.
    Doherty M, Gratton A.
    Brain Res; 2007 May 30; 1150():62-8. PubMed ID: 17395162
    [Abstract] [Full Text] [Related]

  • 5. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW, Widerlöv E, Stanley D, Breese G, Prange AJ.
    J Pharmacol Exp Ther; 1983 Oct 30; 227(1):229-37. PubMed ID: 6620168
    [Abstract] [Full Text] [Related]

  • 6. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW.
    J Pharmacol Exp Ther; 1985 Nov 30; 235(2):544-50. PubMed ID: 4057084
    [Abstract] [Full Text] [Related]

  • 7. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E, Sanna PP, Koob GF.
    Pharmacol Biochem Behav; 2005 Aug 30; 81(4):701-8. PubMed ID: 16005056
    [Abstract] [Full Text] [Related]

  • 8. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB, Gratton A.
    Synapse; 1995 Oct 30; 21(2):110-22. PubMed ID: 8584972
    [Abstract] [Full Text] [Related]

  • 9. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW, Richardson-Carlson R, Duffy P.
    J Pharmacol Exp Ther; 1986 Sep 30; 238(3):1126-31. PubMed ID: 3755755
    [Abstract] [Full Text] [Related]

  • 10. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF, Thatcher-Britton K.
    Prog Clin Biol Res; 1985 Sep 30; 192():499-506. PubMed ID: 3878524
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area.
    Rodaros D, Caruana DA, Amir S, Stewart J.
    Neuroscience; 2007 Nov 30; 150(1):8-13. PubMed ID: 17961928
    [Abstract] [Full Text] [Related]

  • 12. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity.
    Lodge DJ, Grace AA.
    J Pharmacol Exp Ther; 2005 Jul 30; 314(1):201-6. PubMed ID: 15784652
    [Abstract] [Full Text] [Related]

  • 13. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA, Kalivas PW.
    J Pharmacol Exp Ther; 1994 Apr 30; 269(1):437-48. PubMed ID: 8169850
    [Abstract] [Full Text] [Related]

  • 14. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS, Zheng SZ, Feng MJ, Yan SE.
    Brain Res; 2005 Oct 26; 1060(1-2):126-37. PubMed ID: 16212943
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing factor and behavior.
    Koob GF, Bloom FE.
    Fed Proc; 1985 Jan 26; 44(1 Pt 2):259-63. PubMed ID: 3871412
    [Abstract] [Full Text] [Related]

  • 16. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    Pierce RC, Born B, Adams M, Kalivas PW.
    J Pharmacol Exp Ther; 1996 Jul 26; 278(1):384-92. PubMed ID: 8764374
    [Abstract] [Full Text] [Related]

  • 17. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J, Desiraju T, Raju TR.
    Indian J Physiol Pharmacol; 1996 Jan 26; 40(1):15-22. PubMed ID: 8864766
    [Abstract] [Full Text] [Related]

  • 18. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
    Melis MR, Melis T, Cocco C, Succu S, Sanna F, Pillolla G, Boi A, Ferri GL, Argiolas A.
    Eur J Neurosci; 2007 Aug 26; 26(4):1026-35. PubMed ID: 17672853
    [Abstract] [Full Text] [Related]

  • 19. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.
    O'Dell LE, Parsons LH.
    J Pharmacol Exp Ther; 2004 Nov 26; 311(2):711-9. PubMed ID: 15226384
    [Abstract] [Full Text] [Related]

  • 20. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.
    Kalivas PW, Abhold R.
    Brain Res; 1987 Jun 30; 414(2):339-48. PubMed ID: 3620936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.